296 related articles for article (PubMed ID: 16269997)
1. New anticoagulants in ischemic heart disease.
Verheugt FW
Presse Med; 2005 Oct; 34(18):1325-9. PubMed ID: 16269997
[TBL] [Abstract][Full Text] [Related]
2. [The new antithrombotic agents].
Meyer Samama M
Presse Med; 2005 Oct; 34(18):1309-14. PubMed ID: 16269995
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events.
Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
Am J Cardiol; 1998 Sep; 82(5B):19L-24L. PubMed ID: 9737476
[TBL] [Abstract][Full Text] [Related]
4. Use of unfractionated heparin and a low-molecular-weight heparin following thrombolytic therapy for acute ST-segment elevation myocardial infarction.
Wang XK; Zhang Y; Yang CM; Wang Y; Liu GY
Clin Drug Investig; 2006; 26(6):341-9. PubMed ID: 17163268
[TBL] [Abstract][Full Text] [Related]
5. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
[TBL] [Abstract][Full Text] [Related]
6. Clinical potential of antithrombotic drugs in coronary syndromes.
Turpie AG
Am J Cardiol; 1998 Sep; 82(5B):11L-14L. PubMed ID: 9737474
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive low molecular weight heparin during fibrinolytic therapy in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized control trials.
Singh S; Bahekar A; Molnar J; Khosla S; Arora R
Clin Cardiol; 2009 Jul; 32(7):358-64. PubMed ID: 19609890
[TBL] [Abstract][Full Text] [Related]
8. Comparison of low molecular weight heparin with unfractionated heparin during percutaneous coronary interventions: a meta-analysis.
Kodumuri V; Adigopula S; Singh P; Swaminathan P; Arora R; Khosla S
Am J Ther; 2011 May; 18(3):180-9. PubMed ID: 20027109
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy in ST-segment elevation myocardial infarction.
Wong CK; White HD
Expert Opin Pharmacother; 2011 Feb; 12(2):213-23. PubMed ID: 21226633
[TBL] [Abstract][Full Text] [Related]
10. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Harrington RA; Becker RC; Ezekowitz M; Meade TW; O'Connor CM; Vorchheimer DA; Guyatt GH
Chest; 2004 Sep; 126(3 Suppl):513S-548S. PubMed ID: 15383483
[TBL] [Abstract][Full Text] [Related]
12. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis.
Galli M; Andreotti F; D'Amario D; Vergallo R; Vescovo GM; Giraldi L; Migliaro S; Ameri P; Porto I; Crea F
Eur Heart J Cardiovasc Pharmacother; 2020 Jan; 6(1):43-56. PubMed ID: 31350546
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparins in the management of unstable angina.
Agnelli G; Sonaglia F
Haemostasis; 2000; 30 Suppl 2():158-67; discussion 146-7. PubMed ID: 11251362
[TBL] [Abstract][Full Text] [Related]
15. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
16. [Patient with antithrombotic medication. Which do bleedings or preoperative?].
Stiefelhagen P
Laryngorhinootologie; 2006 Jan; 85(1):50-60; quiz 61-5. PubMed ID: 16444657
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
Cohen M; Gensini GF; Maritz F; Gurfinkel EP; Huber K; Timerman A; Krzeminska-Pakula M; Danchin N; White HD; Santopinto J; Bigonzi F; Hecquet C; Vittori L;
J Am Coll Cardiol; 2003 Oct; 42(8):1348-56. PubMed ID: 14563573
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
Magee KD; Sevcik W; Moher D; Rowe BH
Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
Lepor NE
Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
[TBL] [Abstract][Full Text] [Related]
20. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
